5Kimimasa Nakabayashi,Yoshihiro Arimura,Ken Yoshihara,Toshihiro Fukuoka,Miho Karube,Tunee Yamato,Hitoshi Koji,Noriko Ikegaya,Takako Ohtuka,Sohko Kawashima,Miyako Sudo,Akira Yamada.Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience[J]. Modern Rheumatology . 2009 (4)
6Deana D. Hoganson,Aaron M. From,Clement J. Michet.ANCA Vasculitis in the Elderly[J]. JCR: Journal of Clinical Rheumatology . 2008 (2)
7Drooger J C,Dees A,Swaak A J G.ANCA-Positive Patients: The Influence of PR3 and MPO Antibodies on Survival Rate and The Association with Clinical and Laboratory Characteristics. The open rheumatology journal . 2009
8Stratta P,Marcuccio C,Campo A,Sandri L,Messuerott A,Colla L,Rosso S,Mazzucco G,Mariani L,Ciccone G.Improvement in relative survival of patients with vasculitis: study of 101 cases compared to the general population. International journal of immunopathology and pharmacology . 2008
9Martinez Valérie,Cohen Pascal,Pagnoux Christian,Vinzio Stéphane,Mahr Alfred,Mouthon Luc,Sailler Laurent,Delaunay Claire,Sadoun Alain,Guillevin Lo?c.Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis and Rheumatism . 2008
10Hu W,Liu C,Xie H,et al.Mycophenolate mofetil versus cyclophospha-mide for inducing remission of ANCA vasculitis with moderate renal in-volvemen (t J). Nephrology Dialysis Transplantation . 2008
7Jennette JC, Falk RJ, Andrassy K.Nomenclature of systemic vasculitides.Proposal of an international consensus conference.Arsthites Rheum, 1994, 37: 87: 671-192.
8Hagen EC, Daha MR, Andrassy JHK, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney lnt, 1998, 53: 743-753.
9wang Y. Zhao MH. Yu J. et al. The clinical and pathological characteristics of Chinese elderly patients with anti-neutrophil cytoplasmic autoantibodies associated s mall vessel vasculitis Exp Gerontol, 2004, 39: 1401-1405.
4Itabashi M, Takei T, Yabubi Y, et al. Clinical outcome andprognosis of anti-neutrophil cytoplasmic antibody-associatedvasculitis in Japan [J]. Nephron Clin Pract, 2010, 115(1):C12-C27.
5Jennette JC,Falk RJ,Peter A, et al. 2012 revised interna-tional chapel hill consensus conference nomenclature of vascu-litides [J]. Arthritis Rheum, 2013, 65(1) : 1-11.
6Stewart C,Cohen D,Bhattacharyya I, et al. Oral manifesta-tions of Wegener’s granulomatosis: a report of three cases anda literature review[j]. J Am Dent Assoc, 2007,138(3) : 338-348.
